Antonio Zorzano is Full Professor of Biochemistry and Molecular Biology at the University of Barcelona, Group Leader at the IRB Barcelona, and Programme Head at CIBERDEM. Professor Zorzano received his PhD in Biology at the University of Barcelona, and did postdoctoral studies at the Hospital Ramon y Cajal, (Madrid), and at Boston University Medical Center. He has supervised 40 Ph.D. theses, is co-inventor of 21 patents, and has published over 300 scientific articles (more than 31,000 citations, h-index of 82, Google Scholar). He has been founder of biotechnological companies in Spain and in UK.
Professor Zorzano’s research focuses on the regulation of metabolism and its interplay with insulin resistance, obesity and type 2 diabetes. A global goal is to identify and validate molecular targets that permit the prevention or treatment of metabolic diseases by using cell-based systems, genetically modified mice, and translational approaches.